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President-Professor WILSON SMITH, M.D., F.R.S. [February 16, 19491 DISCUSSION: THE SIGNIFICANCE OF STRAIN DIFFERENCES IN VIRUS PROPHYLAXIS.
[Abridged] Dr. W. M. Henderson, Research Institute (Foot-and-Mouth Disease Research Committee), Pirbright, Surrey: There must be few virus diseases in which "strain differences" are not of importance in prophylaxis. I shall deal, mainly, with the significance of strain differences in one disease of animals, namely, foot-and-mouth disease. I believe it is true to say that in this disease the significance of strain differences is so great that their occurrence is one of the biggest obstacles in the way of control by immunization.
It is noteworthy that foot-and-mouth' disease was the first disease of animals or man in which the filtrable nature of the virus was demonstrated. It was also the first virus disease in which the occurrence of major immunological differences was discovered. VallWe and Carre in 1922 [1] reported the existence of two quite distinct immunological types, Vallee 0 and Vallee A. In 1926, Waldmann and Trautwein [2] described the isolation of strains of a third type, Waldmann C. Strains of virus isolated from the great majority of outbreaks of foot-and-mouth disease can be classified as belonging to one of these three immunological types. Infection with one type, although conferring immunity to strains of the homologous type, leaves the animal susceptible to infection with strains of other types. The existence of this extreme strain difference is of such obvious importance in prophylaxis that for the purposes of this discussion it requires but brief mention. This characteristic of foot-andmouth disease virus is not peculiar amongst the viruses causing disease in animals. Similar gross immunological differences between strains are found in vesicular stomatitis of horses, cattle and swine (at least two types); vesicular exanthema of swine (four types have been recorded); equine encephalomyelitis (at least three types) and in African horse sickness (from the published evidence it is difficult to appreciate whether the magnitude of the antigenic differences between strains is as great as in those diseases just cited). This is in contrast to the position among the virus diseases of man as, so far, the natural occurrence of major strain differences has been demonstrated in only one disease, namely, influenza.
Besides the existence of these immunological types, in foot-and-mouth disease at least, there are a number of other strain differences that must be considered. The first is a difference in immunogenicity as judged by the potency of vaccines when tested against the strain of virus from which they were prepared. For example, comparing the protection established in cattle by inactivated virus vaccines prepared from different strains we find the 50 per cent protection dose against homologous virus infection may be as small as 9 c.c. for one strain and as large as 70 c.c. for another strain.
We have no information whether this difference is an actual difference in the immunogenicity of the strain or whether it is a difference in the sensitivity of the strains to the treatment given during the preparation of the vaccine. When we are studying vaccines which involve in their preparation the use of some physical or chemical agent to "inactivate" the virus it is not possible to say whether the amount of antigen available for immunizing purposes is always the same even although the precaution has been taken of estimating by titration the amount of active virus present in the starting material. It must be pointed out that it has still to be shown that the immunogenic differences demonstrated when using one inactivating agent are going to he equally apparent when using another. There is no doubt, however, of the existence of this difference between the protective capacity of vaccines of the same method of preparation, prepared from different strains. In our experience it means that this quality of a newly isolated strain must be examined before it can be assumed that the strain is suitable for use in vaccine production.
Another strain difference that is of considerable practical importance, if one is dependent on the infected animal as the source of virus for vaccine production, is reflected in variation in the yield of infective material, or in the virus content of the infective tissues or fluids. This factor is, of course, greatly affected by the susceptibility of the host but considerable differences in virus content can be demonstrated from observations on many cattle of the same source, age and breed.
To come to the most interesting strain difference of all, the differences in antigenic behaviour found between strains of the same immunological type. The possibility of the existence of such differences in antigenic behaviour was, without doubt, suspected from time to time but it was not until large scale attempts were made to control the disease by vaccination that much attention was given to their occurrence. More recently, the development of the complement-fixation test for type determination has greatly increased the JULY-COMP. MED. 1 facility with which possible "variant" strains can be detected. Much work remains to be done, however, before the true significance of differences in degree of fixation of complement can be appreciated, especially when it comes to the correlation between the results of invitro tests, serum-neutralization tests and vaccination experiments. Traub and Mohlmann [3] , in Germany, attempted to determine the significance as regards vaccination of complement-fixation differences between three A-type variants. UJnfortunately their protocols are not available but they state that although each vaccine gave some protection against all three strains, greater protection was seen against the homologous strain than against the heterologous strains. At Pirbright, the results of studies of strains of virus recovered from outbreaks in Mexico have provided us with the most comprehensive information we have on differences in antigenic behaviour between strains of the same type. This work, some of which I shall now describe, was done along with my colleagues, Dr. Ian A. Galloway and Dr. J. B. Brooksby [4, 5, 6, 7] .
Having classified the strains isolated from Mexico as belonging to Vallee A type, the most important questions were whether vaccine prepared from a stock A type strain of high immunogenicity would protect cattle against infection with Mexican strains of virus and what was the level of immunogenicity of the Mexican strains when used for vaccine production.
A vaccine prepared from our best A type immunizing strain (strain 119) did not, when administered in equivalent dose, give the same measure of protection against infection with Mexican strain MP as it did against infection with strain 119. Six of eight cattle that had received a 30 c.c. dose of vaccine were completely protected against strain 119 infection, whereas all of another group of eight vaccinated cattle reacted on exposure to strain MP infection.
Cross serum-neutralization tests and complement-fixation tests with these two strains showed greater homologous neutralization and fixation respectively. Similar tests were then carried out with Mexican strain MP and a more recently isolated Mexican strain, strain Ml. Here again greater homologous neutralization and fixation were observed in relation to one another and also to strain 119. In view of this difference between strains MP and Ml as shown by these results, their behaviour in a vaccination experiment was investigated. Although vaccine prepared from each strain gave better protection against the homologous virus infection, the differences in the results between the two groups were not sufficiently great to show more than a trend towards slight antigenic dissimilarity.
The question naturally arose of whether a large dose of vaccine would mask the type of antigenic dissimilarity found between strain 119 and the Mexican strains. It has been seen how a 30 c.c. dose of a strain 119 vaccine gave no protection against strain MP infection. In this next experiment groups of eight cattle, vaccinated with 100 c.c. doses of a strain 119 vaccine, were tested against strains 119, MP, and Ml by tongue inoculation. In the group tested with strain 119 six animals showed no reaction and two had primary lesions only. All of each group tested with strain MP and strain Ml respectively developed primary lesions and, in each case, five of the eight developed secondary lesions. All the cattle in the unvaccinated control groups showed complete development of primary and secondary lesions. Thus, even with a large dose of vaccine, the dissimilarity was still apparent.
The practical importance of all this was that the outcome would be uncertain of attempts to control the epizootic in Mexico by the use of stock A type vaccines supplied by different Institutes until information became available on the range of antigenicity of the A type strains used in their preparation. Furthermore, vaccines prepared from Mexican strains should include strains MP and Ml and the isolation and examination of strains should continue for the duration of the epizootic so that further differences in antigenic behaviour might be detected and taken into account.
It is not possible to give any idea of the frequency of occurrence of this type of difference but an apparently close relationship has been found between other strains widely separated as regards origin and time of isolation. It can be seen how, with a veterinary problem such as this, it is possible to perform vaccination experiments under controlled conditions using the natural host of the infection. It is further possible to perform serum-neutralization experiments using virus and serum collected from the natural host, and to use this host as the "laboratory" animal for detection of virus. Change in this kind of procedure need only be made in the complementfixation test when strains of virus must be adapted to the guinea-pig for the preparation of antisera. It is of great comparative interest, therefore, to see what evidence can be presented from the results of these tests on the correlation between the in-vitro methods and the attempt at prophylaxis. One way of summarizing this evidence is shown in diagrammatic form in fig. 1 . It will be seen throughout that there is greater homologous fixation of complement, greater homologous neutralization of virus and greater protection against the homologous virus infection and that each type of test places the virus strains in the same order in relation to each serum or vaccine. Although the picture presented here is a very pretty one, it must be emphasized that we are certainly not yet in a position to say that the result of a vaccination experiment could be forecast from the result of a serum-neutralization test or the much more easily performed complement-fixation test.
These examples from our experience with foot-and-mouth disease show, I need hardly say, that our knowledge of the complexities of the disease are far from complete. They do, I think, indicate, however, that attempted control of this disease by vaccination does not merely mean acquiring the technique of preparing a "good" vaccine. Great attention must be paid to selection of strains 'of as good immunogenicity and of as wide a range of antigenicity as possible, combined with pontinued examination of strains during the course of an epizootic, and with an appreciation of the significance of any strain variation that may occur. Dr. C. H. Andrewes: Many virus diseases of man, particularly the infectious fevers of childhood, give rise to lasting, often life-long immunity; and in none of these are we troubled by the existence of multiple serological races. Yellow fever is in the same category: so, presumably, is dog distemper. In fig. 1 because of a recent report that there are antigenic differences amongst strains of alastrim [1] . The evidence is as yet not very convincing and the reported differences are, I suspect, unlikely to affect prophylactic measures. Similar unconvincing evidence has been offered as regards herpes simplex [2] .
Influenza stands by itself for the importance of strain differences in prophylaxis and I shall deal nearly entirely with that.
Strain differences are probably of much epidemiological importance in poliomyelitis. Strains related to the Lansing strain, which will infect certain rodents, stand serologically apart from others. Amongst those others there exist an unknown number of serological types. But specific prophylaxis against poliomyelitis is not yet "on the map".
Preventive inoculation against dengue looks more like having real importance soon.
Here, according to Sabin and Schlesinger [3] there are more probably at least three serological types, only one of which has been adapted to infect mice. The three types have probably, as have subtypes of influenza A, an antigen in common.
The serological types of arthropod-borne encephalitis viruses are so distinct and so stable that the viruses are called by different names. Thus, we have the forms of encephalitis known as St. Louis, eastern, western and Venezuelan equine, Japanese B and a few others. There are cross-reactions within this group, both with the complement-fixation and neutralization tests [4] , so it is fair to bring them into a discussion of strain differences. Vaccine-prophylaxis has been shown to be possible within this group, but is in the experimental stage as regards man.
The viruses of the psittacosis family offer a different sort of problem. Here there exist a number of related viruses, having biological differences, but so closely similar antigenically that they can only be differentiated by the use of special techniques: there are psittacosis from parrots, ornithosis (a related set of viruses from other birds), mouse pneumonitis, cat pneumonitis, lymphogranuloma venereum, and several strains of pneumonitis viruses from human sources. These differences do not concern us from the point of view of prophylaxis, and we may thankfully turn away from a nasty knotty problem. INFLUENZA Antigenic variation in influenza viruses.-All human influenza viruses yet known fall into one of two groups, A or B, antigenically unrelated, or almost so. Swine influenza is related to A. Within the A group (and within the B group) are minor differences between strains. Though "minor" they are sufficiently large to affect the results of attempts at vaccine-prophylaxis. Differences were first recognized by means of cross-neutralization and cross-immunity tests in mice. It was found that almost any strain was better neutralized by homologous than by heterologous immune sera. In 1936-37 Smith and Andrewes [5] found four strains (W.S., Gatenby, Christie and Talmey) which seemed more specific than others, and strains turning up in later years were yompared against these four specific strains. Most of those occurring between 1937 and 1946 were found to be more closely related to Christie and Talmey than to others. They were related also, with varying degrees of closeness, to the classical American and Australian strains, PR8 and Melbourne. It was, however, possible to obtain widely different ideas as to relationships, if different methods of comparison were used. Besides cross-neutralization and cross-immunity tests in mice, one can employ cross-immunity tests in ferrets, hiemagglutination, neutralization tests in eggs and complement fixation with two kinds of antigens. Complement fixation with non-specific soluble antigens differentiates between viruses A and B with certainty, but takes no account of lesser strain differences. The other tests are apt to give results very hard to interpret, as Glover and I [6] found when trying to discover the relationships of British swine influenza viruses to other strains. No two tests gave quite the same answers. This, then, was the position. Whenever a new strain of virus was isolated, it was found to be rather different from classical strains such as PR8; but we had no knowledge of relationships amongst viruses recovered in different countries in one year, or in one country in successive years. A vaccine trial in the U.S.A. in 1943 gave very promising results, possibly because the vaccine used had, incorporated in it, a recently isolated (Weiss) strain [7] .
Then in 1947 vaccines used both here [8] and in America quite failed to give any protection. The A viruses isolated were decidedly remote antigenically from those used to make the vaccine, and there is little doubt that this fact explains the failure of the vaccines. Where were we to go from here? An unofficial group considering the matter at the 1947 International Microbiological Congress in Copenhagen felt that study of virus strains on an international basis was called for. As a consequence of its recommendations, the World Health Organization asked the Medical Research Council to set up in London a World Influenza Centre to promote co-operation in this field. Its objects were to collect information and, more particularly, strains of virus from epidemics anywhere in the world. It was thus hoped to learn how far apparently new strains of virus caused outbreaks by travelling from country to country, and to attempt classification of influenza viruses on an orderly basis. This centre is now in being at the National Institute for Medical Research, and has been having its first practical trial during the recent Continental influenza epidemic. Viruses have been received from Italy, Switzerland, France and Holland, as well as from this country. These have been studied antigenically and, without waiting for full antigenic study, distributed in the dried state to laboratories in eight different countries. What we have learnt has made me begin to change my ideas on the epidemiology of influenza. I confess that I had the idea that influenza A was almost infinitely labile, that as fast as we made a vaccine the virus would produce another antigenic variant and so always keep one jump ahead of us. The only hope of effective vaccination might then be to obtain virus (as we have just done) from one country, and send it away rapidly to laboratories abroad, so that homologous vaccine might be made there in time to defend the inhabitants against prospective invasion. In fact, it is very doubtful if there would ever be time to do this effectively.
But now I am more hopeful. Strains recovered from this epidemic across the channel seem to be closely related to the strains which occurred in 1947. This antigenic type of virus first appeared in Australia in May 1946, though a 1944 Swedish strain may be related; at the beginning of 1947 it caused outbreaks in Britain, Holland and Sweden and in the U.S.A. In America they call this type A-prime, as it seems to stand rather apart from other A viruses. I do not myself like the term A-prime; it has unspecified limits and is an awkward term for those of us who are at the beginning of attempted classification of the group; one cannot see how it will fit tidily into a final orderly arrangement. These strains, which I shall refer to for convenience as 1947 A, seemed at that time rather homogeneous. Now, the widespread occurrence of a new type of A seems to me to be surpassed in interest only by the virtual disappearance as an important cause of disease of the older A viruses related to PR8. Unless they stage a comeback, we may have to record that, at any rate in Britain and America, they had their swan song in the autumn of 1943. The original strain of A, W.S., recovered in 1933 and perhaps 1934, has never been recognized since in the wild state. Were we at that time at the tail of a dominance of W.S. virus? Have we just been through a decade in which PR8-like viruses were dominant, and have we but lately entered on an era in which prevalent A viruses are related to the 1947 strains? If so, we may be more hopeful of being able to make a vaccine of the topical strain and to use it effectively for a period of years. We shall, on this hypothesis, expect our vaccines to fail us every decade or so, until we have the measure of some new strain. Also, we can always hope that the mutability of influenza A is not infinite and that we may one day have the main possible variants neatly docketed. One can conceive that in the future a polyvalent vaccine may be available; or, alternatively, that the World Influenza Centre will be able to advise countries as to what is coming to them, so that the appropriate vaccine may be taken out of the cold stores where it is all ready and distributed rapidly wherever needed. I will admit that, in talking thus, I am running a little ahead of my facts. We still lack a satisfactory way of estimating how closely A viruses are related to each other. Though we may strongly suspect it, it is not really certain that all the strains of the 1936-46 decade were more closely related to each other than to the earlier, W.S., or to the later, 1947, strains. In fact, I plead guilty to an attempt at over-simplification. I feel, however, that one is occasionally justified in making a heroic effort to see the wood in spite of the trees. In America, a strain study centre under Dr. Magill has been for some time engaged in trying to unravel the interrelations of strains. My colleagues, Drs. Fulton and Dumbell [9] , have lately been attempting the feat by the use of a modified complement-fixation test, involving the specific, not the unspecific, "soluble" antigen. I feel that if this obscure problem could only be clarified the epidemiology of the disease would be much easier to understand. There is one final complication: Several workers, particularly Hirst [10] , have adduced evidence of antigenic changes in strains in the laboratory, consequent upon passage through mice or other experimental animals. The occurrence of such changes seems established; probably, however, they are of minor importance compared with the gross differences between strains such as have significance for epidemiology and prophylaxis. It must be remembered also that animals injected with complex antigens may produce sera of which the antibody populations are not identical, since the animals may show different quantitative responses to the various ingredients injected. Small differences may thus be exaggerated. A remedy is to use pools of sera from several individuals; over-nice distinctions will be thus less likely to intrude themselves. Influenza B: This virus seems to be less important as a cause of widespread epidemics than A; it seems more apt to exist in an endemic form. Moreover, it seems to be a better antigen than A, so that immunity to one variant may be effective against other variants within the B group. In any case, its vagaries have been less studied than for virus A.
Though it bears rather indirectly on prophylaxis, I may perhaps be allowed to suggest a line of enquiry which most intimately concerns comparative pathology. This arises from my tentative suggestion that a broad antigenic group of virus A may become dominant as a cause of human influenza over a period of years. We still do not know where human influenza virus goes to between epidemics. Shope [11] has shown how in the American Middle West swine influenza can be carried on, within lung-worms, from one season to another. The same has not, however, been shown as yet for Britain and other parts of the world. It is not inconceivable that the pig may act as a reservoir for human influenza. British strains of swine influenza are antigenically distinct from Shope's Iowa strain, but not clearly to be separated from human A viruses in general [6] . It would seem worth comparing serologically swine influenza strains with human ones occurring in the same year and country. If, for example, one were at this time to find swine influenza strains having some relationship to 1949 A, the hunt would be definitely up. So, too, it would be important to know whether viruses from odd cases of sporadic influenza in a no-'flu year were serologically close to the strains from preceding or following epidemics; such a finding would suggest that man himself was after all the only reservoir to be considered.
[March 16, 1949] 
DISCUSSION: THE PHARMACOLOGICAL BASIS OF MODERN ANiESTIHESIA
Dr. Andrew Wilson: The use of the terms "general" and "local" anesthetic has recently undergone some modification and it is now more usual to reserve the term anesthetic to describe those agents which produce generalized loss of sensation with loss of consciousness.
The pharmacology of modern anaesthesia also includes those drugs whose actions are designed either to prevent the side-effects of the anesthetic substance, or to diminish the amount of anmsthetic required. So there are perhaps two major aspects for discussion: (1) The anesthetic itselfand the measures adopted to make the anesthetic safe for the patient.
(2) The premedication drugs which are designed to make the patient safe for the anesthetic. I propose to confine myself to a consideration of the first aspect.
The anesthetic agents are mostly simple aliphatic compounds which cause a reversible depression of living tissue. When used in moderate concentrations, these substances produce essentially a descending paralysis of the central nervous system which begins in the cortex, progresses to the spinal cord and finally affects the vital centres in the medulla. This is the basis of the different degrees of anasthesia described by the anesthetist.
For an explanation ofthe action ofanmsthetics on the central nervous system, three essential factors must be taken into account: (1) The nature of the drug. (2) The high sensitivity of the brain cells for the drug. (3) The fact that the blood flow in the brain is greater than in most other tissues.
Many of the theories which have been advanced to explain the phenomenon of narcosis or anoesthesia, however, are based on the study of only one of these factors.
Mode ofaction.-The drugs which are used as anaesthetic agents differ greatly in structure, for they include hydrocarbons, alcohols, ethers, urethanes, sulphones and amides. It has therefore not been possible, except in the case of homologous series, to show any relationship between action and chemical constitution. For this reason, perhaps, many of the theories of narcosis have been founded on an exploration of certain physical properties of the drugs. Thus a correlation has been established between anaesthetic action and the relative solubilities of certain substances in the lipoid and non-lipoid constituents of the cell. This aspect of the subject was studied nearly a hundred years ago by Von Bibra and Harless and was later extended by the work of Meyer and Overton, who showed that there is a relationship between anmsthetic activity and the distribution coefficient of certain drugs in a lipoid/water system. Various other phenomena have been described such as changes in viscosity and the loss of water or dehydration produced in the cells; and with increased technical facilities it has been shown that there is an alteration in the permeability ofthe plasma membrane ofthe cells. These observations, however, fail to give more than an indication of how the drug may gain access to the cells or cell surfaces. They do not afford any explanation of how the drugs influence the function ofthe cell. For it must be remembered that one of the essential features of anaesthetic activity is its reversibility.
The functions of the cerebral cortex are readily depressed by altering its blood supply and there is well-substantiated evidence of the relationship between the physiological activity of the brain and its utilization of oxygen and of glucose. There is little doubt that this relationship is influenced by anesthetics. Thus La'zlo and his colleagues [l] have shown that during ether anaesthesia, the arterial venous oxygen difference falls from 3-7to 2-2vols. Y.,a decrease of 40%. Again, when the cerebral circulation of the dog is perfused at a constant rate with pentobarbitone [2] , the oxygen uptake of the brain and utilization of sugar is reduced by 30%.
Considerable light has been thrown on the subject by the work of Quastel and his colleagues [3, 4] on the effect of the anesthetics on the uptake of oxygen by brain tissue. In a series of well-designed experiments they have demonstrated, in a variety of animals, that
